The PTSD Symptom Scale Interview for DSM-5 (PSS-I-5) is a 24-item semi-structured interview that assesses PTSD symptoms in the past month and makes a diagnostic determination based upon DSM-5 criteria. Respondents with a known trauma history identify a single traumatic event that causes the most current distress. Each of the 24-items is assessed with a single question with no follow-up questions. Symptom items are then rated on a five-point scale of frequency and severity ranging from 0 (not at all) to 4 (6 or more times/week).
Active? Yes
First used: 01 January 1970
Related Topic
PTSDPTSD is generally grouped alongside anxiety disorders given the similar symptomology that is experienced. There is estimated to be over 300 million people living with PTSD globally. MDMA holds significant promise for treating PTSD and is in Phase III of the clinical trial process,
Related Papers
MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorderThis small double-blind placebo-controlled study (n=6) studied the safety (psychological & physiological) of a low dose of MDMA (50-75mg) in women with chronic PTSD and found no adverse effects.
Related Trials
Repeated Ketamine Infusions for Comorbid PTSD and MDD in VeteransThe purpose of this study is to use repeated ketamine infusions as a probe to validate a model of PTSD+MDD that focuses on neuroanatomy and executive functioning.